Inhibitor to Factor IX Following Activated Prothrombin-Complex Concentrate Treatment

• References

• 1 Mannucci PM, Bader R, Ruggeri ZM. Concentrates of clotting-factor IX. Lancet 1976; 1: 41
• 2 Preston RCM, Disadale DJ, Sutcliffe GB, Wyld PJ, Hamlyn JP. Factor VIII inhibitor by-passing activity (FEIBA) in the management of patients with factor VIII inhibitors. Thrombosis Res 1977; 11: 643-651
• 3 Lechner K, Nowotny C, Krinninger B, Zagner M, Deutsch E. Effect of treatment with activated prothrombin complex concentrate (FEIBA) on factor Vlll-antibody level. Thromb Haemostas 1979; 40: 478
• 4 Stenbjerg S, Jorgensen J. Disseminated intravascular coagulation and infusion of factor-Vlll-inhibitor bypassing activity. Lancet 1977; 1: 360
• 5 Anderle K. The clinical application of FEIBA Immuno in factor VIII inhibitor patients. Thromb Haemostas 1977; 38: 347
• 6 Stenbjerg S, Jorgensen J. Resistance to activated F IX concentrate (FEIBA) Scand. J Haematol 1977; 18: 421-426